Angus C. Russell Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

LCTX Quotes by TradingView

Angus C. Russell is of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 87,500 shares of LCTX, which is worth approximately $72,625. The most recent transaction as insider was on Jun 29, 2021, when has been sold 4,720 shares (Common Shares, no par value) at a price of $2.97 per share, resulting in proceeds of $14,018. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.5K
0% 3M change
0% 12M change
Total Value Held $72,625

Angus C. Russell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 29 2021
SELL
Open market or private sale
$14,018 $2.97 p/Share
4,720 Reduced 5.12%
87,500 Common Shares, no par ...
Jun 29 2021
BUY
Exercise of conversion of derivative security
$54,384 $2.2 p/Share
24,720 Added 21.14%
92,220 Common Shares, no par ...

Also insider at

MNKPF
Mallinckrodt plc Healthcare
Director
RVNC
Revance Therapeutics, Inc. Healthcare
Director
TXMD
TherapeuticsMD, Inc. Healthcare
Director
GPCR
Structure Therapeutics Inc.
ACR

Angus C. Russell

Carlsbad, CA

Track Institutional and Insider Activities on LCTX

Follow Lineage Cell Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

News

Receive news related to Lineage Cell Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LCTX